Literature DB >> 22374276

Contrast-enhanced ultrasound of intrahepatic cholangiocarcinoma: correlation with pathological examination.

H-X Xu1, L-D Chen, L-N Liu, Y-F Zhang, L-H Guo, C Liu.   

Abstract

OBJECTIVE: To investigate the correlation between enhancement patterns of intrahepatic cholangiocarcinoma (ICC) on contrast-enhanced ultrasound (CEUS) and pathological findings.
METHODS: The CEUS enhancement patterns of 40 pathologically proven ICC lesions were retrospectively analysed. Pathologically, the degree of tumour cell and fibrosis distribution in the lesion was semi-quantitatively evaluated.
RESULTS: 4 enhancement patterns were observed in the arterial phase for 32 mass-forming ICCs: peripheral rim-like hyperenhancement (n=19); heterogeneous hyperenhancement (n=6); homogeneous hyperenhancement (n=3); and heterogeneous hypo-enhancement (n=4). Among the four enhancement patterns, the differences in tumour cell distribution were statistically significant (p<0.05). The hyperenhancing area on CEUS corresponded to more tumour cells for mass-forming ICCs. Heterogeneous hyperenhancement (n=2) and heterogeneous hypo-enhancement (n=2) were observed in the arterial phase for four periductal infiltrating ICCs. In this subtype, fibrosis was more commonly found in the lesions. Heterogeneous hyperenhancement (n=1) and homogeneous hyperenhancement (n=3) were observed in the arterial phase for four intraductal growing ICCs. This subtype tended to have abundant tumour cells.
CONCLUSION: The CEUS findings of ICC relate to the degree of carcinoma cell proliferation at pathological examination. Hyperenhancing areas in the tumour always indicated increased density of cancer cells.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22374276      PMCID: PMC3587094          DOI: 10.1259/bjr/21653786

Source DB:  PubMed          Journal:  Br J Radiol        ISSN: 0007-1285            Impact factor:   3.039


  20 in total

Review 1.  Biliary tract cancers.

Authors:  P C de Groen; G J Gores; N F LaRusso; L L Gunderson; D M Nagorney
Journal:  N Engl J Med       Date:  1999-10-28       Impact factor: 91.245

2.  Increasing incidence and mortality of primary intrahepatic cholangiocarcinoma in the United States.

Authors:  T Patel
Journal:  Hepatology       Date:  2001-06       Impact factor: 17.425

3.  Increase in mortality rates from intrahepatic cholangiocarcinoma in England and Wales 1968-1998.

Authors:  S D Taylor-Robinson; M B Toledano; S Arora; T J Keegan; S Hargreaves; A Beck; S A Khan; P Elliott; H C Thomas
Journal:  Gut       Date:  2001-06       Impact factor: 23.059

Review 4.  Cholangiocarcinoma: morphologic classification according to growth pattern and imaging findings.

Authors:  Jae Hoon Lim
Journal:  AJR Am J Roentgenol       Date:  2003-09       Impact factor: 3.959

Review 5.  Pathology of cholangiocarcinoma.

Authors:  J H Lim; C K Park
Journal:  Abdom Imaging       Date:  2004-06-23

6.  Intrahepatic cholangiocarcinoma with marked hypervascularity.

Authors:  Y Yoshida; Y Imai; T Murakami; M Nishikawa; M Kurokawa; T Yonezawa; K Tokunaga; Y Fukushima; K Wakasa; T Kim; H Nakamura; M Sakon; M Monden
Journal:  Abdom Imaging       Date:  1999 Jan-Feb

7.  Cholangiocarcinoma: delayed CT contrast enhancement patterns.

Authors:  J M Lacomis; R L Baron; J H Oliver; M A Nalesnik; M P Federle
Journal:  Radiology       Date:  1997-04       Impact factor: 11.105

8.  Intrahepatic peripheral cholangiocarcinoma in cirrhosis patients may display a vascular pattern similar to hepatocellular carcinoma on contrast-enhanced ultrasound.

Authors:  Ramón Vilana; Alejandro Forner; Luis Bianchi; Angeles García-Criado; Jordi Rimola; Carlos Rodríguez de Lope; María Reig; Carmen Ayuso; Concepció Brú; Jordi Bruix
Journal:  Hepatology       Date:  2010-06       Impact factor: 17.425

9.  Changing international trends in mortality rates for liver, biliary and pancreatic tumours.

Authors:  Shahid A Khan; Simon D Taylor-Robinson; Mireille B Toledano; Angus Beck; Paul Elliott; Howard C Thomas
Journal:  J Hepatol       Date:  2002-12       Impact factor: 25.083

Review 10.  The general rules for the clinical and pathological study of primary liver cancer. Liver Cancer Study Group of Japan.

Authors: 
Journal:  Jpn J Surg       Date:  1989-01
View more
  20 in total

1.  Intrahepatic cholangiocarcinoma: expert consensus statement.

Authors:  Sharon M Weber; Dario Ribero; Eileen M O'Reilly; Norihiro Kokudo; Masaru Miyazaki; Timothy M Pawlik
Journal:  HPB (Oxford)       Date:  2015-08       Impact factor: 3.647

2.  Distinguishing intrahepatic cholangiocarcinoma from hepatocellular carcinoma in patients with and without risks: the evaluation of the LR-M criteria of contrast-enhanced ultrasound liver imaging reporting and data system version 2017.

Authors:  Fei Li; Qing Li; Yubo Liu; Jing Han; Wei Zheng; Yini Huang; Xueyi Zheng; Longhui Cao; Jian-Hua Zhou
Journal:  Eur Radiol       Date:  2019-07-11       Impact factor: 5.315

3.  Comparison between M-score and LR-M in the reporting system of contrast-enhanced ultrasound LI-RADS.

Authors:  Li-Da Chen; Si-Min Ruan; Yuan Lin; Jin-Yu Liang; Shun-Li Shen; Hang-Tong Hu; Yang Huang; Wei Li; Zhu Wang; Xiao-Yan Xie; Ming-De Lu; Ming Kuang; Wei Wang
Journal:  Eur Radiol       Date:  2018-12-19       Impact factor: 5.315

Review 4.  Multimodality imaging of intrahepatic cholangiocarcinoma.

Authors:  Kelly Fábrega-Foster; Mounes Aliyari Ghasabeh; Timothy M Pawlik; Ihab R Kamel
Journal:  Hepatobiliary Surg Nutr       Date:  2017-04       Impact factor: 7.293

Review 5.  Contrast-enhanced ultrasound in liver cancer.

Authors:  Simona Leoni; Ilaria Serio; Anna Pecorelli; Sara Marinelli; Luigi Bolondi
Journal:  Hepat Oncol       Date:  2015-01-12

Review 6.  Liver Masses: What Physicians Need to Know About Ordering and Interpreting Liver Imaging.

Authors:  Arman Sheybani; Ron C Gaba; R Peter Lokken; Senta M Berggruen; Winnie A Mar
Journal:  Curr Gastroenterol Rep       Date:  2017-10-18

7.  Effect of contrast-enhanced ultrasound on differential diagnosis of intrahepatic cholangiocarcinoma and arterial phase enhanced hepatic inflammatory lesions.

Authors:  Shanshan Yin; Qiuli Cui; Kun Yan; Wei Yang; Wei Wu; Liping Bao; Minhua Chen
Journal:  Chin J Cancer Res       Date:  2017-06       Impact factor: 5.087

8.  Hepatocellular carcinoma after ablation: the imaging follow-up scheme.

Authors:  Lin-Na Liu; Hui-Xiong Xu; Yi-Feng Zhang; Jun-Mei Xu
Journal:  World J Gastroenterol       Date:  2013-02-14       Impact factor: 5.742

Review 9.  Management of hepatocellular carcinoma: The role of contrast-enhanced ultrasound.

Authors:  Shu-Guang Zheng; Hui-Xiong Xu; Lin-Na Liu
Journal:  World J Radiol       Date:  2014-01-28

10.  Contrast-Enhanced Ultrasound for the Characterization of Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma.

Authors:  Guang-Jian Liu; Wei Wang; Ming-De Lu; Xiao-Yan Xie; Hui-Xiong Xu; Zuo-Feng Xu; Li-Da Chen; Zhu Wang; Jin-Yu Liang; Yang Huang; Wei Li; Jin-Ya Liu
Journal:  Liver Cancer       Date:  2015-10-21       Impact factor: 11.740

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.